Diamond Biofund Inc.
Taiwan Stock Exchange 6901.TW
Diamond Biofund Inc. Shares (Diluted, Weighted) for the year ending December 31, 2023: 778,905,000
Diamond Biofund Inc. Shares (Diluted, Weighted) is 778,905,000 for the year ending December 31, 2023, a 0.74% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.
-
Diamond Biofund Inc. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 773,212,700, a -19.02% change year over year.
-
Diamond Biofund Inc. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 954,861,900, a -4.37% change year over year.
-
Diamond Biofund Inc. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 998,502,194, a 48.06% change year over year.
-
Diamond Biofund Inc. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 674,370,000.
Key data
| Date | Shares (Diluted, Weighted) | Revenue | Cost of Revenue | Gross Profit |
|---|
Market news
Loading...
Taiwan Stock Exchange: 6901.TW
| CEO | Mr. Pan-Chih Yang |
| IPO Date | Sept. 11, 2023 |
| Location | |
| Headquarters | 34th Floor |
| Employees | 28 |
| Sector | Finance |
| Industries | |
Description
Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email